Literature DB >> 30892820

Independent markers of nonalcoholic fatty liver disease in a gentrifying population-based Chinese cohort.

Xianghai Zhou1, Yufeng Li2, Xiuying Zhang1, Ying Ying Guan3, Yindra Puentes4, Fang Zhang1, Elizabeth K Speliotes4,5, Linong Ji1.   

Abstract

BACKGROUND: Prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing in developing countries, but its causes are not known. We aimed to ascertain the prevalence and determinants of NAFLD in a new largely unmedicated population-based cohort from the rapidly gentrifying region of Pinggu, China.
METHODS: We randomized cluster sampled 4002 Pinggu residents aged 26 to 76 years. Data from 1238 men and 1928 women without significant alcohol drinking or hepatitis virus B or C infection were analysed. NAFLD was defined using a liver-spleen ratio (L/S ratio) ≤1.1 on unenhanced abdominal computed tomography (CT) scanning.
RESULTS: Of men and women, 26.5% and 20.1%, respectively, had NAFLD. NAFLD prevalence was highest in younger men and older women. In multivariate logistic regression models, higher body mass index, waist circumference, serum triglyceride, alanine transaminase, and haemoglobin A1c independently increased the odds of NAFLD in both men and women separately. Higher annual household income and systolic blood pressure for men and higher serum uric acid and red meat intake and lower physical activity levels for women also independently associated with higher odds of NAFLD. Individuals with L/S ratio ≤1.1 had linearly increasing rates of obesity, diabetes, and metabolic syndrome that paralleled fatty liver increase.
CONCLUSIONS: NAFLD is common in a gentrifying Chinese population particularly in younger men of high socioeconomic status and older women with sedentary behaviour who eat red meat. Demographic factors add independent risk of NAFLD above traditional metabolic risk factors. A CT L/S ratio of ≤1.1 identifies individuals at high risk of metabolic disease.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  diabetes; nonalcoholic fatty liver disease; obesity; physical activity; red meat

Mesh:

Substances:

Year:  2019        PMID: 30892820      PMCID: PMC6606362          DOI: 10.1002/dmrr.3156

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  30 in total

1.  Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009.

Authors:  Zobair M Younossi; Munkhzul Otgonsuren; Linda Henry; Chapy Venkatesan; Alita Mishra; Madeline Erario; Sharon Hunt
Journal:  Hepatology       Date:  2015-10-24       Impact factor: 17.425

2.  The prevalence of nonalcoholic fatty liver disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu.

Authors:  Lei Shi; Zhong Wu Liu; Yun Li; Cai Gong; Huan Zhang; Li Juan Song; Cheng Yu Huang; Ming Li
Journal:  Biomed Environ Sci       Date:  2012-08       Impact factor: 3.118

3.  Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Andrew Paul DeFilippis; Michael J Blaha; Seth S Martin; Robert M Reed; Steven R Jones; Khurram Nasir; Roger S Blumenthal; Matthew J Budoff
Journal:  Atherosclerosis       Date:  2013-01-29       Impact factor: 5.162

Review 4.  Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review.

Authors:  Veeral H Ajmera; Norah A Terrault; Stephen A Harrison
Journal:  Hepatology       Date:  2017-04-28       Impact factor: 17.425

Review 5.  Nonalcoholic fatty liver disease: a systematic review.

Authors:  Mary E Rinella
Journal:  JAMA       Date:  2015-06-09       Impact factor: 56.272

6.  Associations between dietary intake and the presence of the metabolic syndrome in patients with non-alcoholic fatty liver disease.

Authors:  M Georgoulis; M D Kontogianni; A Margariti; D Tiniakos; E Fragopoulou; R Zafiropoulou; G Papatheodoridis
Journal:  J Hum Nutr Diet       Date:  2015-05-19       Impact factor: 3.089

7.  Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.

Authors:  Lauren A Beste; Steven L Leipertz; Pamela K Green; Jason A Dominitz; David Ross; George N Ioannou
Journal:  Gastroenterology       Date:  2015-08-05       Impact factor: 22.682

8.  Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Mariana Lazo; Ruben Hernaez; Mark S Eberhardt; Susanne Bonekamp; Ihab Kamel; Eliseo Guallar; Ayman Koteish; Frederick L Brancati; Jeanne M Clark
Journal:  Am J Epidemiol       Date:  2013-05-23       Impact factor: 4.897

Review 9.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

10.  Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study.

Authors:  Pauliina Pisto; Merja Santaniemi; Risto Bloigu; Olavi Ukkola; Y Antero Kesäniemi
Journal:  BMJ Open       Date:  2014-03-20       Impact factor: 2.692

View more
  7 in total

1.  The Perirenal Fat Thickness Was Associated with Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus.

Authors:  Yuxian Yang; Shuting Li; Yuechao Xu; Jing Ke; Dong Zhao
Journal:  Diabetes Metab Syndr Obes       Date:  2022-05-11       Impact factor: 3.249

2.  The Morbidity and Comorbidity of Nonalcoholic Fatty Liver Disease and Different Glucose Intolerance Strata in a Community-Based Chinese Population.

Authors:  Xiuying Zhang; Xianghai Zhou; Xueyao Han; Zuodi Fu; Lianying Wang; Yufeng Li; Linong Ji
Journal:  Metab Syndr Relat Disord       Date:  2020-05-27       Impact factor: 1.894

3.  The Association Between Serum Thyrotropin Within the Reference Range and Metabolic Syndrome in a Community-Based Chinese Population.

Authors:  Meng Li; Xiuying Zhang; Xianghai Zhou; Xueyao Han; Rui Zhang; Zuodi Fu; Lianying Wang; Ying Gao; Yufeng Li; Linong Ji
Journal:  Diabetes Metab Syndr Obes       Date:  2020-06-16       Impact factor: 3.168

4.  Predictive And Prognostic Value Of Hepatic Steatosis In Conversion Therapy For Colorectal Liver-limited Metastases: A Propensity Score Matching Analysis.

Authors:  Mi Jian; Wenju Chang; Li Ren; Tianyu Liu; Yijiao Chen; Ye Wei; Qi Lin; Jianmin Xu; Xinyu Qin
Journal:  Cancer Manag Res       Date:  2019-09-11       Impact factor: 3.989

5.  Trends and Inequalities in the Incidence of Acute Myocardial Infarction among Beijing Townships, 2007-2018.

Authors:  Jie Chang; Qiuju Deng; Moning Guo; Majid Ezzati; Jill Baumgartner; Honor Bixby; Queenie Chan; Dong Zhao; Feng Lu; Piaopiao Hu; Yuwei Su; Jiayi Sun; Ying Long; Jing Liu
Journal:  Int J Environ Res Public Health       Date:  2021-11-23       Impact factor: 3.390

6.  Sex- and body mass index-specific reference intervals for serum leptin: a population based study in China.

Authors:  Jiayu Cheng; Yingying Luo; Yufeng Li; Fang Zhang; Xiuying Zhang; Xianghai Zhou; Linong Ji
Journal:  Nutr Metab (Lond)       Date:  2022-08-08       Impact factor: 4.654

7.  Nicotinamide riboside exerts protective effect against aging-induced NAFLD-like hepatic dysfunction in mice.

Authors:  Xue Han; Xiaogang Bao; Qi Lou; Xian Xie; Meng Zhang; Shasang Zhou; Honggang Guo; Guojun Jiang; Qiaojuan Shi
Journal:  PeerJ       Date:  2019-08-28       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.